Uterine (Endometrial) Cancer: Related News

On Our Blog

Pictured: Noah Kauff
Inherited Gene Mutations Linked to Rare Form of Uterine Cancer

A study has found that mutations in the gene BRCA1 are associated with an increased likelihood of developing a rare, aggressive form of uterine cancer.

March 28, 2014
Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
Heated Chemotherapy: Using Robust Science to Guide Clinical Decisions

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

November 15, 2013
Pictured: Joanne Frankel Kelvin, Nadeem  Abu-Rustum & Larissa Temple
Cancer’s Impact on Women’s Fertility and Building a Family after Treatment

Memorial Sloan Kettering experts discuss the impact that cancer and its treatment can have on female fertility, and options for building a family after treatment ends.

September 16, 2013
Pictured: Barbara Raphael & Chioma Enweasor
Summer Fellowship Gives Medical Students the Tools to Become Physician-Scientists

Our summer fellowship program helps medical students learn to become physician-scientists. Read about one of our trainees who investigated an imaging tool for use in patients with a rare uterine cancer.

August 23, 2013
Strategies for Women to Cope with Sexual and Vaginal Health Concerns Related to Cancer

Therapies are often available for women dealing with sexual and vaginal health concerns related to cancer and its treatment.

June 14, 2013
Pictured: Douglas Levine
Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

May 1, 2013
Pictured: Yukio Sonoda
Meet Gynecologic Cancer Surgeon Yukio Sonoda

Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan Kettering have the benefit of an entire team of physicians having input into their care.

March 27, 2013
Pictured: David Finley & Maria Teresa Ruiz Tsukazan
Robot-Assisted Surgery at Memorial Sloan Kettering

Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.

February 25, 2013
Pictured: Dennis Chi
Meet Gynecologic Cancer Surgeon Dennis Chi

Dr. Chi, Deputy Chief of the Gynecology Service, talks about the way Memorial Sloan Kettering’s research and state-of-the-art care help women with ovarian, cervical, and uterine cancers.

February 13, 2013
Pictured: Carol Brown
Meet Gynecologic Cancer Surgeon Carol Brown

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

November 28, 2012
Pictured: Nadeem Abu-Rustum
Meet Gynecologic Surgeon Nadeem Abu-Rustum

Dr. Abu-Rustum, Director of Minimally Invasive Surgery for the Gynecology Service, discusses how the gynecologic cancer care team treats each woman with an individualized approach.

October 22, 2012
Pictured: Richard Barakat
Gynecologic Surgeon Richard Barakat to Be Appointed President of Two Leading Medical Societies

Dr. Barakat will serve as president of two prestigious societies for gynecologic cancer, allowing him to influence how women with these cancers are cared for both in the United States and around the world.

October 1, 2012
Pictured: Nadeem R. Abu-Rustum
Surgeons Develop Method to Reduce Lymph Node Removal in Gynecologic Cancers

Memorial Sloan Kettering surgeons have pioneered a technique that may improve quality of life for women with early-stage gynecologic cancers.

July 9, 2012
Pictured: Nadeem Abu-Rustum
Memorial Sloan Kettering Advances Method to Reduce Removal of Lymph Nodes in Gynecologic Cancers

A team of surgeons led by Nadeem Abu-Rustum has pioneered an approach for treating women with early-stage gynecologic cancers that improves quality of life.

June 6, 2012

Related Media Coverage

Cancers Share Gene Patterns, Studies Affirm

Gynecologic oncologist Douglas Levine discussed a study he led that found that endometrial tumors can be reclassified into distinct subtypes based partly on their genomic makeup and may respond to targeted drugs already being tested in clinical trials.

May 2, 2013